Literature DB >> 27799514

Tobacco Cessation Treatment Pathways for Patients With Cancer: 10 Years in the Making.

Maher Karam-Hage1, Hanadi Ajam Oughli1, Vance Rabius1, Diane Beneventi1, Rosario C Wippold1, Janice A Blalock1, Paul M Cinciripini1.   

Abstract

Tobacco use is the most common cause of preventable morbidity and mortality in the United States; it accounts for one-third of all cancer deaths and is thought to account for half of preventable cancer deaths. This article describes the Tobacco Treatment Program at a major academic cancer center. Patients and employees may access these services in a number of ways. All current smokers and recent quitters are proactively contacted and invited to participate. Services provided are tailored to the motivational level of individual patients and their immediate medical needs. The treatment pathways we present are based on our experience from the last 10 years in treating more than 5,000 unique patients with around 60,000 patient visits. These pathways include behavioral counseling and pharmacotherapy, including first-line, second-line, and off-label medication use. This article describes the program with the goal of providing guidance and ideas to others who are developing treatment programs and providing treatment to tobacco users.
Copyright © 2016 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2016        PMID: 27799514      PMCID: PMC5909831          DOI: 10.6004/jnccn.2016.0153

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  28 in total

Review 1.  Pharmacological interventions for the treatment of smokeless tobacco use.

Authors:  Jon O Ebbert; Karl Fagerstrom
Journal:  CNS Drugs       Date:  2012-01-01       Impact factor: 5.749

2.  Varenicline for smokeless tobacco dependence.

Authors:  A Aggarwal; M Jain; R C Jiloha
Journal:  J Postgrad Med       Date:  2010 Jan-Mar       Impact factor: 1.476

3.  The effect of smoking cessation on quality of life after lung cancer surgery.

Authors:  Bram Balduyck; Peyman Sardari Nia; Anouschka Cogen; Yanina Dockx; Patrick Lauwers; Jeroen Hendriks; Paul Van Schil
Journal:  Eur J Cardiothorac Surg       Date:  2011-04-17       Impact factor: 4.191

4.  Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome.

Authors:  Allen M Chen; Leon M Chen; Andrew Vaughan; Radhika Sreeraman; D Gregory Farwell; Quang Luu; Derick H Lau; Kerri Stuart; James A Purdy; Srinivasan Vijayakumar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-14       Impact factor: 7.038

5.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

Review 6.  Tobacco use and cessation for cancer survivors: an overview for clinicians.

Authors:  Maher Karam-Hage; Paul M Cinciripini; Ellen R Gritz
Journal:  CA Cancer J Clin       Date:  2014-05-09       Impact factor: 508.702

7.  Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer.

Authors:  E R Gritz; R Nisenbaum; R E Elashoff; E C Holmes
Journal:  Cancer Causes Control       Date:  1991-03       Impact factor: 2.506

Review 8.  Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis.

Authors:  Edward J Mills; Ping Wu; Ian Lockhart; Kristian Thorlund; Milo Puhan; Jon O Ebbert
Journal:  Ann Med       Date:  2012-08-06       Impact factor: 4.709

9.  A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India.

Authors:  Raka Jain; Sonali Jhanjee; Veena Jain; Tina Gupta; Swati Mittal; Patricia Goelz; E Paul Wileyto; Robert A Schnoll
Journal:  Nicotine Tob Res       Date:  2013-08-14       Impact factor: 4.244

Review 10.  Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis.

Authors:  A Parsons; A Daley; R Begh; P Aveyard
Journal:  BMJ       Date:  2010-01-21
View more
  17 in total

1.  Improvement of Smoking Abstinence Rates With Increased Varenicline Dosage: A Propensity Score-Matched Analysis.

Authors:  Maher Karam-Hage; George Kypriotakis; Jason D Robinson; Charles E Green; Gurtej Mann; Vance Rabius; Rosario Wippold; Janice A Blalock; Elie Mouhayar; Jean Tayar; Patrick Chaftari; Paul M Cinciripini
Journal:  J Clin Psychopharmacol       Date:  2018-02       Impact factor: 3.153

Review 2.  Tobacco Cessation in Oncology Care.

Authors:  Emily G Kaiser; Judith J Prochaska; Matthew S Kendra
Journal:  Oncology       Date:  2018-06-19       Impact factor: 2.935

3.  Implementation of the Smoking Treatment and Recovery (STAR) program: healthy cancer survivorship through integrated tobacco control.

Authors:  Kathryn L Taylor; Shelby Fallon; Deepa Subramaniam; Kimberly Davis; Chan To; Tania Lobo; Kenneth P Tercyak; Julia Friberg; Mara Tynan; Emily Russell; Waseem Ahmed; Mary Chris Ponder; Lisa Cusaac; Jillian Thompson; Kellie Gardner; Chul Kim; Louis M Weiner
Journal:  J Cancer Surviv       Date:  2019-11-04       Impact factor: 4.442

Review 4.  Considering Systemic Barriers to Treating Tobacco Use in Clinical Settings in the United States.

Authors:  Alana M Rojewski; Steffani R Bailey; Steven L Bernstein; Nina A Cooperman; Ellen R Gritz; Maher A Karam-Hage; Megan E Piper; Nancy A Rigotti; Graham W Warren
Journal:  Nicotine Tob Res       Date:  2019-10-26       Impact factor: 4.244

5.  Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center.

Authors:  Jason D Robinson; Maher Karam-Hage; George Kypriotakis; Diane Beneventi; Janice A Blalock; Yong Cui; Roberto Gonzalez; Jean Tayar; Patrick Chaftari; Paul M Cinciripini
Journal:  Am J Addict       Date:  2022-03-28

6.  Cigarette-smoking characteristics and interest in cessation in patients with head-and-neck cancer.

Authors:  M S C Conlon; S A Santi; M L Meigs; S M Davidson; D Saunders
Journal:  Curr Oncol       Date:  2020-10-01       Impact factor: 3.677

7.  Impact of a tobacco treatment program on abstinence and survival rates among current smokers with head and neck squamous cell carcinoma.

Authors:  Andrew T Day; Kristina R Dahlstrom; Rebecca Lee; Maher Karam-Hage; Erich M Sturgis
Journal:  Head Neck       Date:  2020-06-01       Impact factor: 3.147

8.  The Emergence of a Sustainable Tobacco Treatment Program across the Cancer Care Continuum: A Systems Approach for Implementation at the University of California Davis Comprehensive Cancer Center.

Authors:  Elisa K Tong; Terri Wolf; David T Cooke; Nathan Fairman; Moon S Chen
Journal:  Int J Environ Res Public Health       Date:  2020-05-06       Impact factor: 3.390

9.  Time to put it out - nurse-facilitated tobacco treatment in a comprehensive cancer center.

Authors:  David A Katz; Sarah L Mott; Jane A Utech; Autumn C Bahlmann; Kimberly A Dukes; Aaron T Seaman; Douglas E Laux; Muhammad Furqan; Zachary J Pollock; Mark W Vander Weg
Journal:  Transl Behav Med       Date:  2021-09-15       Impact factor: 3.626

10.  Association of a Comprehensive Smoking Cessation Program With Smoking Abstinence Among Patients With Cancer.

Authors:  Paul M Cinciripini; Maher Karam-Hage; George Kypriotakis; Jason D Robinson; Vance Rabius; Diane Beneventi; Jennifer A Minnix; Janice A Blalock
Journal:  JAMA Netw Open       Date:  2019-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.